MedPath
FDA Approval

Remaxazon External Patch

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
March 9, 2015
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
chondroitin sulfate sodium (bovine)(3 g in 100 g)
Glucosamine(5 g in 100 g)
Capsaicin(.0285 g in 100 g)
Lidocaine(4 g in 100 g)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Remaxazon External Patch

Product Details

NDC Product Code
69379-285
Route of Administration
TOPICAL
Effective Date
March 9, 2015
chondroitin sulfate sodium (bovine)Active
Code: 8QTV3DTT8WClass: ACTIMQuantity: 3 g in 100 g
Code: N08U5BOQ1KClass: ACTIBQuantity: 5 g in 100 g
CapsaicinActive
Code: S07O44R1ZMClass: ACTIBQuantity: .0285 g in 100 g
LidocaineActive
Code: 98PI200987Class: ACTIBQuantity: 4 g in 100 g
© Copyright 2025. All Rights Reserved by MedPath